Gansheng Tan

1 month ago | medrxiv.org | Osvaldo Laurido-Soto |Gansheng Tan |Susan Nielsen |Anna Lea Huguenard

Dr. Leuthardt reports stock ownership in Neurolutions, Face to Face Biometrics,Caeli Vascular, Acera, Sora Neuroscience, Inner Cosmos, Inflexion Vascular, Aurenar, PetalSurgical, Cordance Medical, and Silent Surgical. They serve as a consultant for MonterisMedical, E15, and Neurolutions. They have received licensing fees from intellectual property forNeurolutions, Caeli Vascular, and Inner Cosmos.

Aug 23, 2024 | journals.plos.org | Anna L. Huguenard |Gansheng Tan |Gabrielle Johnson |Markus Adamek

Citation: Huguenard A, Tan G, Johnson G, Adamek M, Coxon A, Kummer T, et al. (2024) Non-invasive Auricular Vagus nerve stimulation for Subarachnoid Hemorrhage (NAVSaH): Protocol for a prospective, triple-blinded, randomized controlled trial. PLoS ONE 19(8): e0301154. https://doi.org/10.1371/journal.pone.0301154Editor: Emma Campbell, PLOS: Public Library of Science, UNITED KINGDOMReceived: April 12, 2024; Accepted: May 17, 2024; Published: August 23, 2024Copyright: © 2024 Huguenard et al.

Mar 19, 2024 | medrxiv.org | Anna L. Huguenard |Gansheng Tan |Gabrielle Johnson |Markus Adamek

I have read the journal's policy and the authors of this manuscript have the following competing interests: ALH and ECL hold equity in the company Aurenar, LLC. The COI as it relates to this trial has been managed by Washington University. NCT04557618This study was supported by the NIH/NINDS under Award Number 1R21NS128307 (to ECL, PB, and GJZ), The American Association of Neurological Surgeons Robert J.